King Pharmaceuticals Research Development Inc

USPTO Trademark & Patent Filings

Trademark applications and grants for King Pharmaceuticals Research Development Inc. King Pharmaceuticals Research Development Inc has 38 trademark applications. The latest application filed is for "OPTIMAL OPIOID PHARMACOTHERAPY IN INDIVIDUALIZED MULTIMODAL ANALGESIA"

Company Profile

KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
King Pharmaceuticals Research and Development, Inc.
King Pharmaceuticals Research and Development, Inc - Madison NJ
King Pharmaceuticals Research and Development, Inc. -
King Pharmaceuticals Research & Development, Inc. -

Trademarks Patents

Patent Applications

Patent Application	Date
Crystal Forms of 2--Adenosine 20130136693 - 13/546595 Moorman; Allan R. ; et al.	2013-05-30
Allosteric Enhancers of th A1 Adenosine Receptor 20120108636 - 13/347999 Baraldi; Pier Giovanni ; et al.	2012-05-03
Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs 20060135466 - 11/155212 Moorman; Allan R. ; et al.	2006-06-22

Patent Grants & Applications

Trademark Applications

Mark Image Registration \| Serial	Trademark Application Date
"OPTIMAL OPIOID PHARMACOTHERAPY IN INDIVIDUALIZED MULTIMODAL ANALGESIA" 85057044	OPTIMAL OPIOID PHARMACOTHERAPY IN INDIVIDUALIZED MULTIMODAL ANALGESIA 2010-06-08
"PAIN WATCH" 77945568	PAIN WATCH 2010-02-26
"PAIN WATCH" 3902997 77945569	PAIN WATCH 2010-02-26
"OPTIMAL FORUM" 77629777	OPTIMAL FORUM 2008-12-09
"REMOXY (OXYCODONE CONTROLLED-RELEASE) CAPSULES" 77612033	REMOXY (OXYCODONE CONTROLLED-RELEASE) CAPSULES 2008-11-11
"REMOXY XRT (OXYCODONE CONTROLLED-RELEASE) CAPSULES EXTRACTION RESISTANT TECHNOLOGY" 77612057	REMOXY XRT (OXYCODONE CONTROLLED-RELEASE) CAPSULES EXTRACTION RESISTANT TECHNOLOGY 2008-11-11
"REMOXY XRT" 77478874	REMOXY XRT 2008-05-20
"XRT" 77478862	XRT 2008-05-20
"MIPEN" 77384725	MIPEN 2008-01-30
"SUMAQUIX" 77384760	SUMAQUIX 2008-01-30
"SUMAJEX" 77384765	SUMAJEX 2008-01-30
"KAIR" 77329426	KAIR 2007-11-14
"KINGONDEMAND" 3931320 77253473	KINGONDEMAND 2007-08-13
"ALTACE HCT" 77196583	ALTACE HCT 2007-06-04
"JMI" 77148986	JMI 2007-04-04
"THROMBI-PASTE" 77103099	THROMBI-PASTE 2007-02-08
"DIATACE" 78884664	DIATACE 2006-05-16
"DIGARD" 78762946	DIGARD 2005-11-29
"PREFEX" 78762952	PREFEX 2005-11-29
"ALPRET" 78762958	ALPRET 2005-11-29
"DIAGARD" 78762942	DIAGARD 2005-11-29
"ASERTRAS" 78717711	ASERTRAS 2005-09-21
"XYTERIS" 78717715	XYTERIS 2005-09-21
"OVATUS" 78717723	OVATUS 2005-09-21
"ZOVATUS" 78717726	ZOVATUS 2005-09-21
"DP" 3049183 78443319	DP 2004-06-29
"THAT LITTLE BIT MORE" 78349713	THAT LITTLE BIT MORE 2004-01-09
"REMOXY" 3362798 76563088	REMOXY 2003-12-03
"THROMBITENE" 78243654	THROMBITENE 2003-04-30
"PANTHER BALM" 78214364	PANTHER BALM 2003-02-13
"AVINZA" 3319329 78176698	AVINZA 2002-10-21
"FLORINEF" 2639632 78063089	FLORINEF 2001-05-11
"Symbol/Image" 2632176 75686727	Symbol/Image 1999-04-19
"OTOCAIN" 2177713 74621759	OTOCAIN 1995-01-17
"Symbol/Image" 1810413 74271762	Symbol/Image 1992-05-04
"DP" 1742709 74268209	DP 1992-04-22
"THEREVAC" 1652129 74096514	THEREVAC 1990-09-13
"LIQUI-CHAR" 1657982 74096783	LIQUI-CHAR 1990-09-13

Company Registrations

SEC

0001367461

King Pharmaceuticals Research & Development, Inc. of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.